Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial (Q44663943)

From Wikidata
Jump to navigation Jump to search
scientific article published in December 2003
edit
Language Label Description Also known as
English
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial
scientific article published in December 2003

    Statements

    Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial (English)
    P Garcia-Alfonso
    X-ACT Study Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit